Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea.
Int J Lab Hematol. 2010 Apr;32(2):239-47. doi: 10.1111/j.1751-553X.2009.01177.x. Epub 2009 Jul 15.
Recently, the Histiocyte Society revised the diagnostic criteria for hemophagocytic lymphohistiocytosis (HLH) to include low or absent natural killer (NK) cell activity, according to local laboratory reference. The aim of this study was to establish reference interval for functional NK-cell activity in 63 healthy Korean individuals using a flow-cytometric assay. We used peripheral blood mononuclear cells (PBMCs) as effector cells and Fluorescein isothiocyanate-labeled K562 cells as target cells. NK-cell activity was calculated using the following equation: NK-cell activity (%) = (test lysis - spontaneous lysis) x 100/(maximum lysis - spontaneous lysis). NK-cell activity was analyzed in 13 known HLH patients and 16 suspected non-HLH patients using a flow-cytometric assay. The mean (+/-SD) cytotoxicity of PBMCs from healthy individuals was 20.9 +/- 5.3% and the reference interval was 11.8-31.9%. The mean NK-cell activity of HLH patients (8.3 +/- 8.9%) was significantly lower (P = 0.001) than that of non-HLH patients (20.1 +/- 7.8%). The sequential changes in NK-cell activity in the HLH group corresponded to clinical and laboratory findings following treatment. We successfully developed a functional NK-cell activity test for use in the clinical laboratory and obtained a reference interval of NK-cell activity from healthy donors. This assay, and associated reference interval, was used to analyze 30 clinically relevant specimens and the results were shown to be well correlated.
最近,组织细胞协会根据当地实验室参考标准修订了噬血细胞性淋巴组织细胞增生症(HLH)的诊断标准,包括低或缺失自然杀伤(NK)细胞活性。本研究旨在使用流式细胞术检测 63 名健康韩国个体外周血单个核细胞(PBMC)中 NK 细胞功能的参考区间。我们使用外周血单个核细胞作为效应细胞,用荧光素异硫氰酸酯标记的 K562 细胞作为靶细胞。使用以下公式计算 NK 细胞活性:NK 细胞活性(%)=(试验裂解-自发裂解)x 100/(最大裂解-自发裂解)。使用流式细胞术检测了 13 名已知 HLH 患者和 16 名疑似非 HLH 患者的 NK 细胞活性。健康个体 PBMC 的平均(+/-SD)细胞毒性为 20.9 +/- 5.3%,参考区间为 11.8-31.9%。HLH 患者的 NK 细胞活性(8.3 +/- 8.9%)明显低于非 HLH 患者(20.1 +/- 7.8%)(P = 0.001)。HLH 组 NK 细胞活性的连续变化与治疗后临床和实验室发现相符。我们成功开发了一种用于临床实验室的功能性 NK 细胞活性检测方法,并从健康供体中获得了 NK 细胞活性的参考区间。该检测方法及其相关参考区间用于分析 30 份临床相关标本,结果相关性良好。